Antidisease vaccines.
Schofield
L
L
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Melbourne, Australia. schofield@wehi.edu.au
D000209:Acute-Phase Proteins / Q000502:physiology; D000328:Adult; D000368:Aged; D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000502:physiology; D017261:Glycosylphosphatidylinositols / Q000502:physiology; D006790:Host-Parasite Interactions; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007223:Infant; D007249:Inflammation; D008288:Malaria / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D017780:Malaria Vaccines / Q000009:adverse effects; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000502:physiology; D015800:Protozoan Proteins / Q000037:antagonists & inhibitors / Q000276:immunology; D015398:Signal Transduction; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism; D014774:Virulence
D000209:Acute-Phase Proteins; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016207:Cytokines; D017261:Glycosylphosphatidylinositols; D017780:Malaria Vaccines; D015800:Protozoan Proteins